| Product Code: ETC7653557 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market - Industry Life Cycle |
3.4 Israel Induced Pluripotent Stem Cells (iPSCs) Market - Porter's Five Forces |
3.5 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By Cell Source, 2021 & 2031F |
3.6 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.8 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.9 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Induced Pluripotent Stem Cells (iPSCs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in the field of induced pluripotent stem cells in Israel |
4.2.2 Growing investments in healthcare and biotechnology sectors in Israel |
4.2.3 Rising prevalence of chronic diseases driving the demand for advanced regenerative medicine solutions |
4.3 Market Restraints |
4.3.1 Stringent government regulations and ethical concerns related to stem cell research in Israel |
4.3.2 Limited awareness and understanding of induced pluripotent stem cell technology among the general population in Israel |
5 Israel Induced Pluripotent Stem Cells (iPSCs) Market Trends |
6 Israel Induced Pluripotent Stem Cells (iPSCs) Market, By Types |
6.1 Israel Induced Pluripotent Stem Cells (iPSCs) Market, By Cell Source |
6.1.1 Overview and Analysis |
6.1.2 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Cell Source, 2021- 2031F |
6.1.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Skin Cells, 2021- 2031F |
6.1.4 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Blood Cells, 2021- 2031F |
6.2 Israel Induced Pluripotent Stem Cells (iPSCs) Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Human IPSCs, 2021- 2031F |
6.2.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Mouse IPSCs, 2021- 2031F |
6.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market, By Product |
6.3.1 Overview and Analysis |
6.3.2 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Instruments, 2021- 2031F |
6.3.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Consumables & Kits, 2021- 2031F |
6.3.4 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Israel Induced Pluripotent Stem Cells (iPSCs) Market, By Applications |
6.4.1 Overview and Analysis |
6.4.2 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.4.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Regenerative Medicine, 2021- 2031F |
6.4.4 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Cellular Therapy, 2021- 2031F |
6.4.5 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Toxicology Screening, 2021- 2031F |
6.4.6 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.4.7 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Development, 2021- 2031F |
6.4.8 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Induced Pluripotent Stem Cells (iPSCs) Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Biotechnology & Pharmaceutical Companies, 2021- 2031F |
6.5.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.5.4 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.5.5 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Induced Pluripotent Stem Cells (iPSCs) Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.6.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 Israel Induced Pluripotent Stem Cells (iPSCs) Market Import-Export Trade Statistics |
7.1 Israel Induced Pluripotent Stem Cells (iPSCs) Market Export to Major Countries |
7.2 Israel Induced Pluripotent Stem Cells (iPSCs) Market Imports from Major Countries |
8 Israel Induced Pluripotent Stem Cells (iPSCs) Market Key Performance Indicators |
8.1 Number of research collaborations between Israeli biotech companies and academic institutions focusing on induced pluripotent stem cells |
8.2 Percentage of healthcare budget allocated to stem cell research and regenerative medicine in Israel |
8.3 Rate of adoption of induced pluripotent stem cell therapies in clinical trials and medical treatments in Israel |
9 Israel Induced Pluripotent Stem Cells (iPSCs) Market - Opportunity Assessment |
9.1 Israel Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By Cell Source, 2021 & 2031F |
9.2 Israel Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By Product, 2021 & 2031F |
9.4 Israel Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.5 Israel Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 Israel Induced Pluripotent Stem Cells (iPSCs) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Induced Pluripotent Stem Cells (iPSCs) Market - Competitive Landscape |
10.1 Israel Induced Pluripotent Stem Cells (iPSCs) Market Revenue Share, By Companies, 2024 |
10.2 Israel Induced Pluripotent Stem Cells (iPSCs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here